Reclassification Opens Doors For Needed Medical Research Into Benefits And Risks
May 5, 2026
Assoc. professor of nursing who studies cannabis breaks down some of the possibilities moving forward in a rescheduled world
Assoc. professor of nursing who studies cannabis breaks down some of the possibilities moving forward in a rescheduled world
An update on the Trump administration’s rescheduling announcement
The order also states that “unlicensed bulk marijuana” remains classified as a Schedule I controlled substance
“This action recognizes the longstanding regulation of medical marijuana by state governments and the need for a common-sense approach to this reality.”
The two main subjects up for discussion in DC were the appropriation bill that redefined “hemp,” and the movement of marijuana to Schedule III
Featuring experts from Mass General Hospital and the Cannabis Chamber of Commerce, among other institutions
“Responsible cannabis consumers must no longer be threatened with federal prosecution and prison simply for exercising their 2nd Amendment rights.”
“This change has the potential to expand access to evidence-based therapies while maintaining strong safeguards”
Neither the president nor his spokespersons have provided any further updates regarding either their intentions or their timeline
Answers about Trump’s potential reclassification of marijuana including what could happen to current state programs
